FierceBiotech Feb 4, 2026 NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable
FierceBiotech Feb 4, 2026 Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech Feb 4, 2026 Amgen advances toward lupus redemption while gastric cancer candidate struggles
Endpoints News Feb 4, 2026 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Thermo Fisher Feb 4, 2026 Thermo Fisher Scientific Inc. $TMO Shares Sold by Alta Capital Management LLC - MarketBeat
Illumina Feb 4, 2026 Mediolanum International Funds Ltd Makes New $914,000 Investment in Illumina, Inc. $ILMN - MarketBeat
Lonza News Feb 4, 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Agilent Feb 4, 2026 Allianz Asset Management GmbH Has $96.71 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Charles River Feb 4, 2026 Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs - Contract Pharma
Hologic Feb 4, 2026 FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening - Contemporary OB/GYN
10x Genomics Blog Feb 4, 2026 10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Lonza News Feb 4, 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
10x Genomics Blog Feb 4, 2026 Rate Hike: Can 10x Genomics Inc grow without dilution - July 2025 Summary & High Return Trade Guides - baoquankhu1.vn
Thermo Fisher Feb 4, 2026 Thermo Fisher Scientific launches kit to simplify liver cell gene expression and help advance early-stage drug discovery - SelectScience
Illumina Feb 4, 2026 What Catalysts Are Shifting The Illumina (ILMN) Story For 2026 And Beyond - Yahoo Finance